try to keep your feet grounded Every stock/biotech has a great story of a wonder drug or wonder platform for producing drugs.
Nothing has changed in the last 2 months.
Urocidin is still 12 months+ away from find out any information.
Econiche really is dead in the water. U.S. is where you need approval, not Mongolia or some other country.
Plant/Facory: Is probably the most near term potential as they come on line and hopefully announce some outsourcing contracts.
Immucodin: Just got approved, potential for partnering in the next 60 days, however sales won't be anywhere near meaningful untill maybe this time next year.
Keep in mind that there is over 45 million in loans and the clock is ticking.
I'm long at .90 but wish I would have bought recently like someone else posted. If this stock cracks $1.00, I think I would take my money and run because this has been a horrible stock to invest in.